CD274 and neoplasm: On the contrary, TAMs may also suppress the recruitment of MDSCs to the tumor or inhibit the T cell immune response directly by elevating expression of the immunosuppressive ligand PD-L1, thus providing a novel target for cancer immunotherapy [261].